Mechanisms of resealing and rebuilding in muscle repair
Mechanisms of resealing and rebuilding in muscle repair
批准号:
10734597
负责人:
ALEXIS R. DEMONBREUN
金额:
$40.0万
依托单位国家:
美国
项目类别:
财政年份:
2003
资助国家:
美国
项目状态:
未结题
起止时间:
2003-07-01 至 2028-04-30
关键词:
ActinsAcuteAnnexin A6AnnexinsAreaCellsChronic DiseaseCytoplasmDNA Sequence AlterationDYSF geneDefectDependenceDiseaseDominant-Negative MutationEventExtracellular MatrixF-ActinFamily memberGeneticGenetic DiseasesHealthHomologous GeneHourInjuryMembraneMolecularMuscleMuscle ContractionMuscle functionMuscular AtrophyMuscular DystrophiesMyoblastsOutcomePharmacologyPhasePolymersProcessProliferatingProteinsResearchResolutionRoleSarcolemmaSarcomeresShoulderSiteTherapeuticTimeTraumaVisualizationWorkcell motilitycell typeextracellularimprovedinjuredinjury and repairmigrationnovelpolymerizationprogenitorprogramsrecruitrepairedsealtool
中文摘要
点击翻译按钮获取中文摘要
英文摘要
Muscle repair is essential to maintain normal muscle function. Muscle injury, whether due to trauma or
overuse, is associated with a loss of muscle membrane integrity. Resealing the disrupted sarcolemma is a
critical step needed for muscle repair. Subtypes of muscular dystrophy arise from genetic mutations that
weaken the sarcolemma, rendering it prone to disruption and requiring robust repair mechanisms. Other
subtypes of muscular dystrophy arise from genetically-driven deficits in repair proteins, and these genetic
disorders have illustrated proteins and mechanisms that contribute to membrane stability and membrane
repair. Studies of injured muscle and dystrophic muscle have uncovered phases of muscle repair, an
immediate resealing phase followed by a rebuilding phase. Sarcolemmal resealing occurs through the
formation of a cap at the site of muscle membrane disruption. We and others have shown that this cap is
enriched for annexin proteins, especially annexin A6, a modifier of muscular dystrophy. Dominant negative
annexin A6 disrupts the formation of the repair cap, through its effects on annexin assembly, leading to
excessive membrane leak and ineffective repair. The repair cap is supported by a ring of “shoulder” proteins
that serve to reinforce the resealing process, and these proteins include dysferlin, MG53, and EHD proteins.
Within the muscle cytoplasm immediately abutting sarcolemmal disruption is an active area that is enriched for
actin and the dysferlin related protein, Fer1L5. Moreover, actin polymerization is required for normal resealing.
Recent work highlighted the role of muscle rebuilding, which follows sarcolemma resealing and includes
sarcomere assembly. Through this research program, we previously demonstrated the role of ferlin proteins
and annexins in sarcolemmal resealing by optimizing high-resolution real-time visualization. We also
developed novel genetic tools to elucidate the interaction of these proteins in membrane events. We now
propose to investigate the role of resealing proteins in their interaction with the actin-rich region in Aim 1. In
Aim 2, we will examine the molecular and temporal overlap of resealing and rebuilding during muscle repair. In
Aim 3, we will use biologically active decellularized matrices to define and probe the role of extracellular
annexins in regulating cellular contributions to muscle repair in health and disease. The outcomes of this work
will discover new protein-cellular interactions to guide the pharmacology of promoting muscle repair.
期刊论文(9)
专著(0)
科研奖励(0)
会议论文
DOI:
10.1016/b978-0-12-385940-2.00008-5
发表时间:
2011
期刊:
CURRENT TOPICS IN DEVELOPMENTAL BIOLOGY
影响因子:
--
作者:
[Posey, Avery D., Jr., Demonbreun, Alexis, McNally, Elizabeth M.]
通讯作者:
McNally, Elizabeth M.
A KCNE1 missense variant (V47I) causing exercise-induced long QT syndrome (Romano Ward).
KCNE1 错义变异 (V47I) 导致运动诱发的长 QT 综合征 (Romano Ward)。
DOI:
10.1016/j.ijcard.2011.08.022
发表时间:
2012
期刊:
International journal of cardiology
影响因子:
3.5
作者:
[Ryan,JohnJ, Kalscheur,Matthew, Dellefave,Lisa, McNally,Elizabeth, Archer,StephenL]
通讯作者:
Archer,StephenL
Extracellular matrix regulation of cellular crosstalk in cardiac fibrosis
-
批准号:10634954
-
项目类别:
-
资助金额:$70.7万
-
财政年份:2023
-
负责人:ALEXIS R. DEMONBREUN
-
依托单位:
Development of anti-LTBP4 as a biologic to treat Neuromuscular Diseases
-
批准号:10647744
-
项目类别:
-
资助金额:$56.53万
-
财政年份:2022
-
负责人:ALEXIS R. DEMONBREUN
-
依托单位:
Development of anti-LTBP4 as a biologic to treat Neuromuscular Diseases
-
批准号:10467836
-
项目类别:
-
资助金额:$149.49万
-
财政年份:2022
-
负责人:ALEXIS R. DEMONBREUN
-
依托单位:
海外基金